Navigation Links
BioTox Sciences (BTS) Deploys eStudy™ Hosted Solution for Management of GLP & Non-GLP Preclinical Studies
Date:3/9/2011

CARY, N.C., March 9, 2011 /PRNewswire/ -- iAdvantage Software, Inc., a leading solutions provider for managing development and pre-clinical life science studies, today announced that BioTox Sciences (BTS), a GLP Contract Research Organization, headquartered in San Diego, California, is deploying the eStudy™ hosted solution to manage its GLP and Non-GLP preclinical/nonclinical studies.

(Logo: http://photos.prnewswire.com/prnh/20110309/CL62195LOGO)

In 2010, BioTox Sciences expanded its resources from people to facility to accommodate growing Sponsors' needs.  The final challenge was selecting a software platform that would handle the different preclinical study types BTS conduct's today, yet flexible enough to meet the ever-changing needs they may encounter as they continue to grow.

"After weighing our options and careful due diligence, BioTox Sciences chose to implement eStudy, by iAdvantage Software," commented Tareq Abu-Nadi, BioTox Sciences, Business Development/Study Director.  "eStudy will complement and streamline the study processes conducted at BTS by increasing productivity and speed of reporting while maintaining 21 CFR parts 58 and 11 compliance."

"eStudy's flexibility ensures that BTS Study Directors would be able to use eStudy on various projects and multiple species.  Whether a typical 28 day toxicity study in rats or dogs, or a long term surgery study in NHPs, eStudy will be used to manage the study, capture the data and allow for on-demand reporting of results upon Sponsor request.  This significant investment gives us the ability to produce complete study books in mere hours, and help Sponsors make key decisions on development of compounds and initiate more projects," concluded Abu-Nadi.

eStudy is a 100% web-based study management platform that iAdvantage Software hosts for BTS at Cegidem/Dendrite's world-class network operating center in Chesapeake, VA.  "eStudy will continually grow with BioTox Sciences, easily adapt to new study-types, marry to BTS' operational work-flow and interface with 3rd party instruments and tools," stated Diana Michelotti, Director of Marketing and Sales for iAdvantage.  "eStudy implemented for BTS, provides BTS with a custom fit solution without the start-from-scratch price."

About iAdvantage SoftwareiAdvantage is dedicated to empowering scientists and management in the pharmaceutical and biotechnology arenas with efficient, web-based electronic study management and reporting tools that automate cumbersome tasks and optimize time to results thereby improving productivity, real-time business intelligence and time to market.

iAdvantage products include eStudy, a truly web-based enterprise solution for study design, eNotebook design, collection of data from multiple sources, multiple users and multiple locations, integration of data in real-time to a secure storage device, maintaining data integrity (complying with 21 CFR Parts 58 and 11) with the flexibility of on-demand access, data analysis and reporting that is user-defined and user-controlled.  iAdvantage places control in the hands of the scientist and not at the mercy of rigid study management systems.

iAdvantage is headquartered in Cary, North Carolina, near the life science and biotech hub of Research Triangle Park.  More than 140 life science companies in North America and Europe use iAdvantage products in their research and development.  Please visit www.iadvantagesoftware.com for more information.

About BioTox SciencesBioTox Sciences, San Diego, CA, is a leading Contract Research Organization (CRO) offering comprehensive services for nonclinical and preclinical studies operates a state of the art 20,000 sqf AAALAC accredited vivarium.  BioTox Sciences services encompass toxicology, pharmacology, metabolism, disease models, surgery models, behavior and safety testing, PK/PD and other customized testing in support of nonclinical drug development for pharmaceutical, biotechnology and medical device companies.  Visit www.biotoxsciences.com/ for more information.Inquires:Diana MichelottiDirector of Marketing and SalesiAdvantage Software, Inc. - 919-469-3888 ext. 121dmichelotti@iadvantagesoftware.comTareq Abu-NadiBusiness Development/Study DirectorBioTox Sciences - 858-605-5882 ext. 302tabunadi@biotoxsciences.com
'/>"/>

SOURCE iAdvantage Software, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
3. RBC Life Sciences Reports Sales and Earnings Growth in 2010
4. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
5. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
6. Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries
7. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
8. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
9. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
10. Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care
11. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):